Colitis Kit

Works on Colitis/Ulcerative Colitis by reducing the inflammation in the colon and also eliminating the causes of inflammation by regulating the sub clinical amoeba (protozoa)/ bacterial infection in the intestinal crypts

Each 40 Day Kit Contains:

• Stomium® - 1 Bottle of 160 Tablets
• Acidim® - 2 Bottles of 160 Tablets
• Xembran - 1 Bottle of 120 Tablets
  

This kit works on fighting the cause of Colitis, Ulcerative Colitis with loss of blood, healing intestinal crypts & thus reducing inflammation, restoring normalcy.

HOW IT WORKS:

Modern lifestyle and eating habits lead to the weakening of intestinal linings resulting in a sub clinical amoeba / bacterial infection attacking the intestinal crypts. The infection then multiplies due to weakness of the intestine and causes inflammation of the colon known as Colitis. It distorts immune system so immune system is not able to fight it out and it can multiply and stay inside you for ever, causing more diseases. Allopathy science is unable to deal with it, unfortunately.

Stomium® attacks the sub clinical amoeba infection and causes it to become weak overtime.

Xembran® is a herbal bacteriostatic and its bactericidal action works along with the body's defense mechanism to eliminate the harmful bacteria e.g. H Pylori.

Acidim® maintains optimum pH of the intestinal crypts to create a unfavourable environment for the infection and plasmolyse it thereby healing the intestinal tract and reducing the inflammation of the colon, thereby helping treat colitis.

RESEARCH:

Colitis patients have an increased frequency of activated T cells, demonstrated by the expression of activation markers and cell proliferation. Grocare®'s Latest Research shows significant activity of combination of Stomium®, Acidim® & Xembran® against the T cell activation phases:

1. Activation marker expression - Minimum 40% reduction in CD28 & 65% reduction in CD28 Marker 
   
2. Secretion of functional and cytotoxic molecules - Minimum 50% reduction in IL-2, Granzyme & Perforin secretion 
   
3. Clonal expansion/proliferation - 80% reduction in cell proliferation
   

Published Research Report confirms Xembran's action against H Pylori in a conclusive way. Click here to see report.

Research work on mice with artificially induced inflammatory bowl disease (IBD) . From Intenstine CD8+ T cells, CD4+ T cells and regulatory T cells Tregs were isolated and analyzed for their activity.

Rationale – In IBD intestinal CD8+ T cells and CD4+ T cells have highly increased activity whereas Tregs do not show efficiency to control immune system. For drug activity CD8+ and CD4+ activation should go down and Tregs activation should go up.

Results –

Description          Mouse CD8 T            Mouse CD4 T               Mouse Tregs

                                Cell Activation.       Cell Activation.            Activation

 Control.                    100                               100                                 100

Mesalamine                85                                  81                                   99

Acidim+Xembran

 +Stomium.                71                                   68                                124

1. Mesalamine decreased the CD8+ and CD4+ T cell activity but did not affect Tregs
2. Combination of Acidim, Xembran and Stomium decreased CD8+ and CD4+ T cell activity significantly better that mesalamine and also increased the Tregs activity very significantly.

DOSAGE:

2 tablets Acidim® after breakfast, Lunch and dinner

2 tablets Stomium® after breakfast and dinner

1 tablet Xembran® after breakfast and 2 tablets after dinner.

Note : If the Colitis is chronic and suffering from long time, we suggest that auto immunity caused by it must be corrected by adding Absogen® - 1 capsule after breakfast and 1 capsule after dinner. This can be ordered from www.grocareherbals.com/products/absogen

 TIMELINE:

Benefits like relief in pain and discomfort should be visible in a few weeks. Total Treatment generally takes about 4-6 months but may vary depending on the severity of the case.